ZBIO — Zenas BioPharma, Inc. stock price, charts and financials

QT75Zenas BioPharma, Inc.

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.50
-0.47-1.47%
OverviewShort InterestFilings
ZBIOQT75Zenas BioPharma, Inc.·NASDAQ
31.50-1.47%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 11, 2026S-3ASRS-3ASR
Sep 11, 2026S-8Registration of employee benefit securities
Sep 08, 2026SC 13GBeneficial ownership statement (passive)
Sep 08, 20263Initial statement of beneficial ownership
Sep 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 02, 20264Statement of changes in beneficial ownership
Sep 02, 20263Initial statement of beneficial ownership
Aug 19, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 17, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 13, 20268-KCurrent report
Aug 13, 202610-QQuarterly report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 13, 20268-KCurrent report
May 13, 202610-QQuarterly report
May 05, 2026SC 13DBeneficial ownership statement (active)
#1 / 25 of 187
Page
▼
/ 8